





Academic Medical Centers (AMCs) are an integral component of the health care system in the United States. With such a unique purpose and sweeping influence, AMCs play an indispensable role in transforming the health care delivery system. To transition from volume to value, value-based purchasing programs play an equally important role. The purpose of this study is to understand if the hospital value-based purchasing program is achieving its stated goal of improving patient outcomes, safety, and patients’ care experience in the academic medical center setting. Objectives include evaluating how AMCs have been impacted by this program, what results have been realized so far, and if any adverse effects exist. This will be accomplished by reviewing literature and publications relevant to hospital value-based purchasing in the context of academic medical centers and the broader category of tertiary care providers.
Pay-for-performance and value-based purchasing programs preceding the hospital value-based purchasing program, showed no statistically significant results on clinical quality, outcomes, costs, unintended effects, and effects on disparities in the hospital setting. In 2016, 64% of teaching hospitals received penalties, while only 36% received bonuses. Under the hospital value-based purchasing program, academic medical centers are currently at a financial disadvantage due to the vulnerable populations they serve, along with the cost and implications of teaching and researching. It is critical to innovation and redesign that AMCs flourish and thrive, with enough funding to achieve their tripartite mission of care, research, and education. They function as an incubator for cutting-edge treatments, are responsible for training future generations of medical professionals, and act as a safety net for the communities they serve. They are the economic engine of many communities and improve the health of the people that surround them. Although there is limited quantifiable outcomes associated with HVBP’s goals currently, the program is an important and necessary step in the evolution of the United States health care system. Outcomes and results must be analyzed intensively and used to constantly improve value-based purchasing measures. The hospital value-based purchasing program is significant to public health because many people can’t afford the medical care they need right now.
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Academic Medical Centers (AMCs) are an integral component of the health care system in the United States. Unlike most acute care providers, their mission is tripartite: patient care, education, and research. “AMCs graduate nearly 17,000 MDs every year, provide more than 40% of charity care, and account for 20% of all hospital admissions, surgical operations, and outpatient visits.” (PwC Health Research Institute, 2012) They are also the worldwide leaders in research. “The Association of American Medical Colleges (AAMC) estimates that medical schools and teaching hospitals conduct more than half of all extramural research sponsored by the National Institutes of Health (NIH).” (PwC Health Research Institute, 2012). Beyond their mission, AMCs provide a major stimulus for the economy. According to the AAMC, the combined economic impact of the nation’s AMCs exceeded $500 billion in 2008 and they were responsible for the creation of more than 3 million full-time jobs. (PwC Health Research Institute, 2012) With such a unique purpose and sweeping influence, AMCs play an indispensable role in transforming the health care delivery system.   
The purpose of this study is to understand if the hospital value-based purchasing program is achieving its stated goal of improving patient outcomes, safety, and patients’ care experience in the academic medical center setting. Objectives include evaluating how AMCs have been impacted by this program, what results have been realized so far, and if any adverse effects exist. This will be accomplished by reviewing literature and publications relevant to hospital value-based purchasing in the context of academic medical centers and the broader category of tertiary care providers.
It is important to define and differentiate between terminology for the scope of this study. Value-based purchasing (VBP) refers to a broad set of performance-based payment strategies that tie financial incentives to health care providers' performance on a set of clear measures to achieve better value. (Damberg, et al., 2014) There are numerous types of VBP programs such as: pay-for-performance programs (P4P), accountable care organizations (ACOs), bundled payments, and shared savings. This study will focus on HVBP specifically, which is a P4P program. Additionally, it is important to note that terms “academic medical center” and “academic health center”, are interchangeable. Each term is used throughout various publications and research documents. Academic medical center will be the preferred terminology for this study, unless literature sources specifically use the term “academic health center”. AMCs are defined as having an affiliation agreement with a recognized medical school. Currently, AAMC has accredited 147 medical schools. (Association of American Medical Colleges, 2017) After reviewing all pertinent literature, an analysis will be conducted to synthesize all materials to derive meaning, insight, and understanding of what relationships may exist.
Today, AMCs face the most challenging environment yet. The cost of health care in United States has reached unsustainable levels. In 2015, U.S. health care spending increased 5.8% to reach $3.2 trillion. Furthermore, the overall share of the U.S. economy devoted to health care spending was 17.8% in 2015, up from 17.4% in 2014. (CMS, 2016) Even though the United States ranks the highest in the world on healthcare spending, the U.S. ranks the lowest on health performance indicators among 11 comparable nations. (World Health Organization, 2012) Although provider organizations, insurance companies, and government payers have attempted to improve quality and lower cost since the 1990s, the Patient Protection and Affordable Care Act (ACA) launched unprecedented reforms to improve healthcare value. (Chee, Ryan, Wasfy, & Borden, 2016) One component of this legislation, is Hospital Value-Based Purchasing (HVBP). HVBP is part of the Centers for Medicare & Medicaid Services’ (CMS) ongoing work to structure Medicare’s payment system to reward providers for the quality of care they provide. “This program rewards acute care hospitals with incentive payments for the quality of care they give to people, not just the quantity of services they provide.” (CMS, 2017) While efforts like these are necessary, it is unclear whether the HVBP program has achieved the outcomes it was designed for.
2.0 	Literature review
To understand how the HVBP program has impacted AMCs, a literature review is essential. Gathering and synthesizing publications from industry experts was necessary to understand what developments and outcomes have already been identified. First and foremost, literature on pay-for-performance programs will be examined, followed by reviewing environmental forces on academic medical centers. Next, value-based purchasing programs in the context of academic medical centers will be assessed. The literature review will then be concluded by an analysis of hospital value-based purchasing results.
2.1	Pay-for-performance Programs
Perhaps the most comprehensive and credible literature available on assessing VBP programs was published by the RAND Corporation in 2014. To help inform policymaking, the U.S. Department of Health and Human Services (HHS) commissioned RAND to review what has been learned over the past decade about VBP. “This article summarizes the current state of knowledge about VBP based on a review of the published literature, a review of publicly available documentation from VBP programs, and discussions with an expert panel composed of VBP program sponsors, health care providers and health systems, and academic researchers with VBP evaluation expertise.” (Damberg, et al., 2014) “The authors report on VBP program goals and what constitutes success; the evidence on the impact of these programs; factors that characterize high– and low–performing providers in VBP programs; the measures, incentive structures, and benchmarks used by VBP programs; evidence on spillover effects and unintended consequences; and gaps in the knowledge base.” (Damberg, et al., 2014) RAND’s analysis focused on three types of models: pay-for-performance, accountable care organizations, and bundled payments. This research report, titled: “Measuring Success in Health Care Value-Based Purchasing Programs”, is superior in methodological quality and more thorough than any of its kind. In the environmental scan portion of the report, the group reviewed 129 VBP programs. Of these programs, 91 were P4P-based.  After the environmental scan was completed, the group examined all peer-reviewed published literature between January 1, 2000, and April 30, 2013. The methodological quality of each study was assessed based on the strength of presented evidence, then they were graded as good, fair, or poor quality. Lastly, after their literature review, the group convened an expert panel to address study questions where there was a void in data. Since HVBP falls into the category of P4P, the review of this literature will focus specifically on P4P content. To be precise, attention will be directed towards P4P programs within the hospital setting. The authors’ research goes beyond the scope of this study – including physician group and long-term care settings as well as recommendations for VBP programs.
2.1.1	Clinical Quality
Damberg et al identified 49 studies that assessed the effect of P4P on process and intermediate outcome measures. Of those 49 studies, 11 studies were on process measures in the hospital setting. The published studies focused on the following few large P4P interventions: the Premier demonstration, the Physician Group Practice demonstration, the Integrated Healthcare Association P4P program, the Blue Cross Hawaii P4P program, the Massachusetts multi-plan P4P program, the UK Quality Outcomes Framework P4P program, and the Blue Cross Blue Shield of Massachusetts AQC. “Overall, the results of the studies were mixed, and studies with stronger methodological designs were less likely to identify significant improvements associated with the P4P programs.” (Damberg, et al., 2014) Studies that found a significant association between P4P and higher levels of quality were of weaker design.
2.1.2	Outcomes
The group reviewed 21 studies on outcomes, 6 of which were in the hospital setting. This subset of studies focused mostly on measuring the effects on morality. Only 3 of the outcome studies were deemed methodological good quality and results were mixed. Damberg et al noted:

Glickman found no evidence that in-hospital mortality improvements were 
incrementally greater at P4P hospitals in the CMS Premier Hospital Quality 
Incentive Demonstration (HQID) program, while Ryan found no evidence that 
the HQID had a significant effect on risk adjusted 30-day mortality acute myocardial 
infarction, heart failure, pneumonia, or coronary artery bypass graft (CABG). 
Sutton et al found that risk-adjusted mortality for the conditions included in the 
P4P program decreased by 1.3% compared with controls in a study evaluating a 
program in the UK modeled after CMS HQID.

Only one other study was deemed to be of fair quality; it found no differences between hospitals in the HQID experiment and hospitals exposed to pay-for-reporting, although the authors noted both sets of hospitals maxed out performance measures, so there was no differential effect to detect.
2.1.3	Costs
RAND found limited studies that investigated the influence of P4P on costs. They only found two studies in the hospital setting which look at changes in costs. “Both studies were based on the HQID, and neither found any significant effects on hospital costs, revenues, margins or Medicare payments.” (Damberg, et al., 2014)
2.1.4	Unintended Effects
Damberg et al examined unintended consequences in addition to spillover effects to evaluate any undesired effects from P4P programs. Undesired behaviors include: ignoring other clinical areas that are not incentivized or measured by the P4P program, providing care that is not recommended clinically, avoiding more challenging or sick patients when providing care, overtreating patients, provider gaming of data to increase scores, an increase in disparities in treatment or outcomes among patients, as well as harmful effects of VBP on providers who serve higher acuity patient populations. The group found 21 articles which examined undesired behaviors and spillover effects of these programs. They found the majority of published evidence regarding undesired behaviors showed either modest or no effects. “However, recent studies in the Veteran’s Administration found evidence of overtreatment of patients with hypertension and diabetes associated with use of intermediate outcome measures that use thresholds.” (Damberg, et al., 2014) RAND’s literature review found only 5 studies that examined spillover effects from P4P programs. “The P4P studies have found mixed effects, with some finding no effects (either positive or negative) on measures that were non-incentivized, one finding negative effects, and, in a few cases, evidence of improvement on non-incentivized measures within the same conditions that were the target of the incentives.” (Damberg, et al., 2014)
2.1.5	Effects on Disparities
Numerous studies on P4P have commented on the possibility of adverse effects for patients of low socio-economic status and the providers which serve them. It is challenging, however, to examine whether VBP programs increase disparities or work to reduce them due to lack of information on patients’ race, ethnicity, education, and socioeconomic status. RAND only found 5 empirical studies assessing the relationship between P4P and disparities. “Among the four studies that evaluated U.S. P4P programs, three found no effects related to increasing or decreasing racial/ethnic or SES disparities while one poor-quality study found very small significant differences in baseline performance for hospitals with a high disproportionate share hospital index comparing HQID P4P and pay-for-reporting hospitals.” (Damberg, et al., 2014) Another study with robust design features, found no negative access effects in relation to avoidance of treating minority patients after the Premier HQID was introduced.
2.1.6	Summary
Overall, the results for the RAND research study were mixed. Evidence published on improvements in performance from P4P experiments is either modest or null. In the hospital setting, little to no effect was seen on clinical quality, outcomes, costs, unintended effects, and effects on disparities. Methodological weaknesses exist predominately throughout published studies evaluating the impact of P4P programs. Damberg et al conclude: “Although the past decade has witnessed a fair amount of experimentation with performance-based payment models, primarily P4P programs, we still know very little about how best to design and implement VBP programs to achieve stated goals and what constitutes a successful program.” Since the group’s literature review only assessed publications up until April 30th, 2013, it was not possible for their research to include results from the HVBP program, or other VBP programs that have been implemented more recently. It would be beneficial for the RAND corporation to reconvene and evaluate present publications and results.
2.2	Environmental forces on Academic Medical centers
In February of 2012, PricewaterhouseCoopers (PwC) Health Research Institute conducted an analysis on the future external environment academic medical centers will face. In the past, AMCs have been financially successful through a complex mix of revenues sources to achieve their three-prong mission of clinical care, research, and education. “Research and education have been loss leaders, cross-subsidized by the work of hospitals and physicians. So any changes to clinical revenue directly impact an AMC’s ability to educate clinicians and scientists and to conduct research.” (PwC Health Research Institute, 2012) PwC cites three major forces that will require AMCs to change: budgetary and political pressures will raise the threat level at AMCs, low quality rankings and imprudent affiliations could damage the AMC brand, and the old AMC structure is not designed to address new challenges. The first two forces PwC attributed to necessitating change, political pressures and quality rankings, are both associated to HVBP. 
The Research Institute interviewed AMC leaders, most of which expressed concern about funding the future of their tripartite mission. These leaders mentioned the shift toward “value-based purchasing” based on measures related to quality and patient satisfaction in Medicare and performance and risk-based payments structures for private payers. (PwC Health Research Institute, 2012) Of the AMC leaders, 38% of them recognized meeting new quality standards as a revenue threat. Additionally, now that CMS and commercial payers require detailed quantitative measures on outcomes, the top quality rankings AMCs have enjoyed in the past may decline. Cited in this analysis was a report from The Joint Commission (TJC), which showed few major AMCs in their hospital rankings. It is evident from this report that VBP has impacted AMCs, even before the legislation had been implemented.  VBP would cause a 1% reduction to the base DRG payment in 2013, incrementally increasing to 2% by 2017, shown below in Figure 1:

Figure 1. DRG Payment Percentage Withheld for HVBP
Source: (CMS, 2017)
Another question in PwC Health Research Institute AMC Leader Survey asked: Which of the following best describes how your organization is addressing funding and revenue challenges? 75% of leaders said, “improved quality outcomes” would be their strategy. With publicly sharing quality scores and a percentage of revenue at stake, it would seem from this survey that AMC leaders recognize the need to change and increase their focus on quality. Although this report does not measure any of the outcomes of HVBP, it does share insight into how leaders have responded to this P4P program.
2.3	Value-based purchasing and academic Medical centers
Published in the Academic Medicine Journal, Harold Miller wrote a commentary titled: “Making Value-Based Payment Work for Academic Health Centers”. The author describes how current “value-based purchasing initiatives fail to address the underlying problems in fee-for-service payment and can be particularly problematic for academic health centers (AHCs)”. (Miller, 2015) He suggests that the use of bundled payments, warranties, and condition-based payments can address these issues. This will enable both hospitals and physicians to reengineer care delivery without causing financial strain for themselves. While this article focuses mostly on payment reform, rather than how VBP measures effect AHCs, the author does mention two problems regarding P4P programs. First, Miller suggests the small payment adjustments of HVBP do not offset the higher costs or diminished operating margin the provider might experience in delivering higher-quality care or reducing spending. Next, the author states that the quality and efficiency measures used in HVBP are problematic for AHCs due to the unique patients they treat. “No risk adjustment system can adequately address the unusual health problems treated in AHCs or the social challenges faced by the inner-city populations they often serve.” (Miller, 2015) The problem with this article is that is it more of an opinion paper – based on personal belief rather than quantitative data. Very few sources are cited in this commentary, several of which reference his own work. Although these arguments seem to make logical sense, there are no cited reports or studies verifying his statements. Finally, a conflict of interest may exist as Harold Miller is president and CEO of the Center for Healthcare Quality and Payment Reform.
2.4	Hospital Value-based purchasing Results








While analyzing this table an inherent flaw became evident, particularly in regard to the percent of hospitals that are AMCs. Table 1 depicts that, of the hospitals that received bonuses, 6.9% of them were AMCs. Given 1,806 hospitals received bonuses, this would mean roughly 125 AMCs fell into the bonus category. Additionally, the graph depicts that of the hospitals that received penalties, 17.9% of them were AMCs. Given 1,235 hospitals received penalties, this would mean approximately 221 AMCs received penalties. The sum of the AMCs that received bonuses and penalties equates to 346 hospitals. This calculation would not include the AMCs that didn’t receive a payment adjustment. By the standard definition of an AMC, there are 147 hospitals that qualify for this designation. This discrepancy could be contributed to two possible factors, either a mathematical error exists within the data, or the definition of an AMC in this text differs from the generally accepted definition. Interestingly enough, according to the AAMC, there are nearly 400 major teaching hospitals in the United States. One might deduce that the author was referring to teaching hospitals, rather than AMCs in this example. Nevertheless, of teaching hospitals that received payment adjustments, 64% received penalties versus 36% that received bonuses. 
2.4.1	Value-Based Purchasing’s Ability to Change Behavior 










Figure 2. Histogram of Value-Based Modifier's Estimated Effect on Total Patient Revenue
Source: (Muhlestein, 2015)

Figure 2 shows that a considerable majority of hospitals either receive bonuses or are penalized for a small percentage of their total patient revenue. The author states: “With relatively small bonuses or penalties and a high investment in implementing changes required for an unknown potential return, the financial incentives may not be sufficient to justify significant changes for many hospitals.” It is also mentioned that additional analysis needs done to evaluate if hospitals with larger payment adjustments improved more than those with smaller ones.  
2.4.2	Meaningful Differences in Performance Translate to Meaningful Differences in Payment 
The second policy revisions Muhlestein suggests is CMS should only structure quality measures so only meaningful differences in performance lead to meaningful differences in payments. This is illustrated perfectly by an example in the text regarding a patient experience survey question:

For 2015 (the most recently available data), the percent of patients at a hospital
that said that their doctor always communicated well ranged from 70% to 96%, but 
the difference between the 50th percentile and the 25th percentile is only three
percentage points (81 compared to 78). Given the sample sizes of respondents from 
some of the hospitals, this difference will often not be statistically significant but 
the absolute difference will lead to meaningful differences in performance scores 
for the HVBP program. (Muhlestein, 2015)














The third recommendation made for the HVBP program is to decrease measurement volatility. To illustrate this, Table 3 above shows the change of HVBP scores between 2015 and 2016 broken down by quintile. Variations in hospital performance year over year are drastic and unpredictable. Significant increases and decreases in performance might be indicative of the program not adequately measuring true quality. “For example, one hospital was in the lowest quintile in 2013, the highest quintile in 2014, back to the lowest quintile in 2015 and is now in the middle quintile in 2016.” (Muhlestein, 2015) Between the different years, 224 hospitals saw at least a two-quintile improvement and two-quintile decline. Movement like this suggests the program measures may be vulnerable to random variation versus hospital performance substantially declining or improving each year. A confounding variable could be changes to scoring methodology, but it is mentioned that modest scoring changes were made between 2015-2016 and observed variation cannot be attributed exclusively to this factor. To address this issue, Muhlestein proposes increasing the numbers of cases needed for each metric. For hospitals with low case volume, an alternative HVBP program could be designed.  
2.4.4	Overlap with other Medicare Initiatives
Finally, the last opportunity for improvement is to consider combining the Hospital Readmission Reduction Program (HRRP) and the Hospital Acquired Conditions Reduction Program (HAC) with HVBP. This action would allow CMS to better align measures across the programs and reduce duplication. A lack of coordination exists between the programs currently. “For example, the Agency for Healthcare Research and Quality Patient Safety 90 indicator is used for both the HVBP program and the HAC program.” (Muhlestein, 2015) Although the correlation between HVBP and HRRP scores is insignificant (corr=0.06), the correlation between HVBP and HAC scores is more meaningful (corr=0.24). Both HVBP and the HAC reduction program, for example, use rates of central line-associated bloodstream infections and catheter-associated urinary tract infections to calculate performance. (McKinney, 2013). CMS has acknowledged this circumstance but explained it was appropriate to include incentive under more than one program given infections such as these are of critical importance to improving inpatient quality. Muhlestein’s analysis provides valuable insight into how the HVBP program is effecting hospitals across the United States. From his observations, it is possible to conclude that adverse effects exist for AMCs and hospital alike.
3.0 	Methodology
To conduct the literature review, a Search, Appraisal, Synthesis, and Analysis (SALSA) framework was employed. Search mediums utilized consisted of the PubMed database as well as an unrestricted online exploration. The search process began by defining key terminology critical to finding relevant published literature, unpublished documents, and other source material. Beginning with obvious terms such as “hospital value-based purchasing” and “academic medical centers”, the scope of the research was refined and then expanded. The HVBP search was expanded to the broader category of “value-based purchasing” in addition to “pay-for-performance programs”. It was discovered that the terminology “academic health center” was used in several publications, thus, the search was expanded to include this term along with “academic medical centers”. Furthermore, beyond the AMC setting, the general “hospital term” was used. These terms were then associated with one another in search fields. The appraisal process of publications and articles found was conducted simultaneously to the search process. Notes were taken, strengths and weaknesses were identified, and questions were recorded for each reference. The synthesis and analysis process also occurred concurrently to one another, as key points were identified and related to other sources of information. 
	It was essential to conduct an effective literature to define key terminology. Value-based purchasing (VBP) refers to a broad set of performance-based payment strategies that tie financial incentives to health care providers' performance on a set of clear measures to achieve better value. (Damberg, et al., 2014) Hospital value-based purchasing is part of the CMS’s ongoing work to structure Medicare’s payment system to reward providers for the quality of care they provide. (CMS, 2017) Academic medical centers are defined as tertiary and quaternary health care providers who have an affiliation agreement with a recognized medical school by the AAMC. Currently, AAMC has accredited 147 medical schools. (Association of American Medical Colleges, 2017)
Several limitations were identified thorough the study. The most substantial limitation was the lack of literature available evaluating the effectiveness of the HVBP program. Since hospitals receive payment adjustments based on performance two years prior, there is currently only three years of data available. There were no scholarly studies or publications found reviewing the most recent year’s payment adjustments or results. Moreover, the complexity of the subject requires a prolific knowledge base and intensive analysis skills. As demonstrated in the RAND research report, the analysis and assessment of the HVBP program requires a collective of industry professionals, subject experts, and government officials. The AMC environment and the HVBP program contains a multitude of confounding, interwoven variables, which makes it difficult to isolate specific effects.

4.0 	Results/findings




While the HVBP program is still in its infancy, it seems there is still some refinement needed before it will achieve the outcomes it was created for. There has the been tremendous speculation regarding AMCs being disadvantaged due to the acuity of their cases, and the socio-economic status of the patients they serve; the results of this analysis would agree with those statements. I think it would be appropriate to add a case mix adjustment factor in the calculation for the HVBP scores. Given the importance of AMCs in the evolution of the health care system, putting them at a disadvantage would be to the detriment of making progress in reform. I also believe that it makes logical sense to combine the numerous quality improvement programs CMS has instituted into one, comprehensive VBP program. This would eliminate redundancy and overlap between current programs, and would enhance the clarity of measures and objectives. In return, it would make it easier for health care providers to focus their efforts and produce meaningful change. Healthcare in general, is behind the information technology curve. The lack of published outcomes is a result of having limited data to analyze, along with a lack of concerted effort to use data to drive decision making. While the HVBP program is an important attempt to drive change in hospitals to reduce costs and increase quality, experts and leaders need to continue to evaluate results and use them to continually improve the value in value-based purchasing.

6.0 	conclusion
Under the hospital value-based purchasing program, academic medical centers are currently at a financial disadvantage due to the vulnerable populations they serve, along with the cost and implications of teaching and researching. It is critical to innovation and redesign that AMCs flourish and thrive, with enough funding to achieve their tripartite mission of care, research, and education. They function as an incubator for cutting-edge treatments, are responsible for training future generations of medical professionals, and act as a safety net for the communities they serve. They are the economic engine of many communities and improve the health of the people that surround them. Although there are limited quantifiable outcomes associated with HVBP’s goals currently, the program is an important and necessary step in the evolution of the United States health care system. Outcomes and results must be analyzed intensively and used to constantly improve value-based purchasing measures. The hospital value-based purchasing program is significant to public health because many people can’t afford the medical care they need right now.
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